JHM BioPharma (Tonghua) Co. , Ltd.
4 clinical trials · Sponsor
◉ Watch JHM BioPharma (Tonghua) Co. , Ltd.
| Record | Firm | Date |
|---|---|---|
| Efficacy and Safety of Recombinant Botulinum Toxin Type A (Eveotox) for Injection in the Treatment of Adult Upper Limb Spasticity . (NCT07242300) | JHM BioPharma (Tonghua) Co. , Ltd. | 2025-12-11 |
| Efficacy and Safety of Recombinant Botulinum Toxin Type A (Eveotox) for Injection to Treat Moderate to Severe Glabellar Lines (NCT06937944) | JHM BioPharma (Tonghua) Co. , Ltd. | 2025-04-30 |
| A Clinical Study to Evaluate the Safety and Efficacy of JHM03 in Adult Patients With Upper Limb Spasticity (NCT06584240) | JHM BioPharma (Tonghua) Co. , Ltd. | 2024-09-14 |
| A Phase I/II, Randomized, Double-blind, Placebo, and Active Controlled Clinical Study to Evaluate the Safety, Tolerability, Immunogenicity, and Preliminary Efficacy of JHM03 in Subjects With Moderate to Severe Glabellar Lines (NCT06199336) | JHM BioPharma (Tonghua) Co. , Ltd. | 2024-01-19 |
Track JHM BioPharma (Tonghua) Co. , Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.